Actively Recruiting
Evaluating the Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System for Patients with Refractory Right Heart Failure
Led by Shenzhen Core Medical Technology CO.,LTD. · Updated on 2026-07-15
6
Participants Needed
2
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and feasibility of the CorVad Percutaneous Ventricular Assist System CorVad RS in patients with refractory right heart failure who continue to have unstable blood flow despite receiving the best medical treatments. This device is designed to support the right ventricle by sharing some or all of its workload during the support period. The study focuses on patients who develop right heart failure after events such as left ventricular assist device implantation, myocardial infarction, heart transplantation, or open-heart surgery. Participants will receive the CorVad RS device, which is intended to provide hemodynamic support by assisting the right ventricle. The study is a single-group interventional trial where all participants will use this device. There is no placebo or comparison group described. The device will be implanted and used to support heart function, and the researchers will monitor safety and device feasibility throughout the treatment phase. Participants will be monitored for survival rates at 30 days after device removal or hospital discharge, whichever is longer, or until transition to longer-term therapy. Other assessments include tracking death rates at 30 and 90 days post-device removal, major bleeding, hemolysis, pulmonary embolism, valve dysfunction, heart-related adverse events, and changes in heart function parameters during and after device support. The study will also observe reductions in the use of medications that support heart function. The total participation duration extends through these follow-up periods to evaluate outcomes and safety.
CONDITIONS
Brief Title
Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure
Research Team
X
Xiaoli Shi
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here